Profile data is unavailable for this security.
About the company
Imara, Inc. is a clinical-stage biopharmaceutical company. The Company is developing and commercializing therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin. The Company’s product pipeline include IMR-687, which is an oral, once-a-day, potentially disease-modifying treatment for sickle cell disease (SCD), and beta-thalassemia. Its IMR-687 is a selective, small molecule inhibitor of phosphodiesterase-9 (PDE9). The Company is conducting a Phase 2a clinical trial of IMR-687 in adult patients with SCD and a Phase 2b clinical trial for the treatment of patients with beta-thalassemia.
- Revenue in USD (TTM)--
- Net income in USD--
- Incorporated--
- Employees16.00
- LocationImara Inc116 HUNTINGTON AVENUE, 6TH FLOORBOSTON 02116United StatesUSA
- Phone+1 (617) 206-2020
- Fax+1 (302) 655-5049
- Websitehttps://imaratx.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Evofem Biosciences Inc | 278.00k | -114.43m | 230.02m | 53.00 | -- | 5.72 | -- | 827.42 | -1.93 | -1.93 | 0.0047 | 0.4947 | 0.0037 | -- | 0.2843 | 5,245.28 | -151.24 | -239.25 | -323.65 | -402.08 | 21.94 | -- | -41,161.15 | -- | 1.51 | -2.46 | 0.5444 | -- | -- | -- | 36.37 | -- | 55.43 | -- |
| Neubase Therapeutics Inc | 0.00 | -17.38m | 233.63m | 3.00 | -- | 7.46 | -- | -- | -0.9026 | -0.9026 | 0.00 | 1.35 | 0.00 | -- | -- | -- | -74.01 | -87.20 | -84.14 | -100.52 | -- | -- | -- | -- | -- | -63.09 | 0.0044 | -- | -- | -- | 33.47 | -- | 31.12 | -- |
| Otonomy Inc | 313.00k | -45.01m | 237.76m | 49.00 | -- | 3.16 | -- | 759.62 | -1.33 | -1.33 | 0.0088 | 1.56 | 0.003 | -- | -- | 6,387.76 | -43.42 | -47.27 | -48.48 | -50.70 | -184.35 | -- | -14,379.87 | -10,950.49 | -- | -45.23 | 0.1678 | -- | -19.46 | -- | 11.30 | -- | -2.19 | -- |
| Sol Gel Technologies Ltd | 10.73m | -29.40m | 240.82m | 61.00 | -- | 4.21 | -- | 22.44 | -1.37 | -1.37 | 0.4989 | 2.49 | 0.1599 | -- | 3.08 | 175,967.20 | -43.81 | -- | -49.42 | -- | -- | -- | -273.91 | -- | -- | -- | 0.00 | -- | 17,655.04 | -- | 23.58 | -- | -- | -- |
| AVEO Pharmaceuticals, Inc. | 5.90m | -28.54m | 241.71m | 19.00 | -- | 5.38 | -- | 40.99 | -1.54 | -1.54 | 0.3131 | 1.56 | 0.0888 | -- | 5.51 | 310,368.40 | -42.99 | -49.79 | -59.92 | -99.99 | -- | -- | -483.99 | -162.43 | -- | -- | 0.2529 | -- | 432.35 | 9.70 | 276.17 | -- | -- | -- |
| Chiasma Inc | 142.00k | -67.02m | 242.78m | 48.00 | -- | 2.20 | -- | 1,709.70 | -1.45 | -1.45 | 0.003 | 1.91 | 0.0009 | -- | 1.59 | 2,958.33 | -44.46 | -42.03 | -48.95 | -48.21 | 97.89 | -- | -47,195.77 | -- | 8.95 | -21.68 | 0.00 | -- | -- | -- | -16.18 | -- | -- | -- |
| Clever Leaves Holdings Inc | 0.00 | -847.40k | 242.99m | 4.00 | -- | 1.20 | -- | -- | -0.2282 | -0.2282 | 0.00 | 8.16 | 0.00 | -- | -- | 0.00 | 0.0951 | -- | 0.0954 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -1,828.87 | -- | -- | -- |
| Imara Inc | -100.00bn | -100.00bn | 244.40m | 16.00 | -- | 2.58 | -- | -- | -- | -- | -- | 5.45 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -106.96 | -- | -- | -- |
| Checkpoint Therapeutics Inc | 1.07m | -21.68m | 245.74m | 8.00 | -- | 6.78 | -- | 230.31 | -0.4533 | -0.4533 | 0.0213 | 0.5336 | 0.0376 | -- | 6.93 | 133,375.00 | -76.45 | -- | -102.05 | -- | -- | -- | -2,032.05 | -- | -- | -- | 0.00 | -- | -51.28 | -- | 32.04 | -- | -- | -- |
| Palatin Technologies, Inc. | -267.95k | -21.87m | 245.99m | 20.00 | -- | 3.20 | -- | -- | -0.0929 | -0.0929 | -0.0011 | 0.3349 | -0.0027 | -- | -- | -13,397.50 | -21.96 | -10.23 | -23.69 | -15.34 | -- | -- | -- | -15.96 | 7.43 | -- | 0.00 | -- | -99.80 | -60.92 | -162.69 | -- | -- | -- |
| Metacrine Inc | -100.00bn | -100.00bn | 248.14m | 35.00 | -- | 2.52 | -- | -- | -- | -- | -- | 3.79 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.0866 | -- | -100.00 | -- | -12.05 | -- | -- | -- |
| Aptinyx Inc | 2.48m | -52.34m | 253.03m | 43.00 | -- | 1.72 | -- | 101.90 | -1.26 | -1.26 | 0.0584 | 2.33 | 0.0212 | -- | 6.92 | 57,744.19 | -44.64 | -- | -46.91 | -- | -- | -- | -2,108.06 | -- | -- | -- | 0.00 | -- | -44.19 | -- | -7.75 | -- | -- | -- |
| 9 Meters Biopharma Inc | 0.00 | -65.44m | 253.32m | 8.00 | -- | 51.64 | -- | -- | -0.9605 | -0.9605 | 0.00 | 0.0242 | 0.00 | -- | -- | 0.00 | -551.76 | -306.57 | -26,912.24 | -- | -- | -- | -- | -521.25 | -- | -44.36 | 0.2589 | -- | -- | -- | -11.95 | -- | -- | -- |
| CTI BioPharma Corp | 0.00 | -45.64m | 254.34m | 25.00 | -- | 5.31 | -- | -- | -0.6791 | -0.6791 | 0.00 | 0.6351 | 0.00 | -- | -- | 0.00 | -75.01 | -67.27 | -107.38 | -106.96 | -- | -- | -- | -221.29 | -- | -52.11 | 0.1078 | -- | -87.28 | -43.88 | -36.12 | -- | -- | -- |
| OncoSec Medical Inc | 0.00 | -45.72m | 255.98m | 42.00 | -- | 12.34 | -- | -- | -1.71 | -1.71 | 0.00 | 0.5861 | 0.00 | -- | -- | 0.00 | -159.94 | -113.86 | -236.24 | -137.28 | -- | -- | -- | -- | -- | -513.74 | 0.0734 | -- | -- | -- | -39.56 | -- | -- | -- |
Data as of Jan 22 2021. Currency figures normalised to Imara Inc's reporting currency: US Dollar USD
40.32%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| OrbiMed Advisors LLCas of 30 Sep 2020 | 2.72m | 15.63% |
| Fidelity Management & Research Co. LLCas of 30 Sep 2020 | 2.48m | 14.23% |
| Deerfield Management Company LPas of 30 Sep 2020 | 517.65k | 2.97% |
| Rock Springs Capital Management LPas of 30 Sep 2020 | 358.94k | 2.06% |
| BlackRock Fund Advisorsas of 30 Sep 2020 | 306.87k | 1.76% |
| RA Capital Management LPas of 30 Sep 2020 | 249.74k | 1.44% |
| The Vanguard Group, Inc.as of 30 Sep 2020 | 180.54k | 1.04% |
| Geode Capital Management LLCas of 30 Sep 2020 | 82.92k | 0.48% |
| SSgA Funds Management, Inc.as of 30 Sep 2020 | 64.01k | 0.37% |
| Northern Trust Investments, Inc.(Investment Management)as of 30 Sep 2020 | 61.08k | 0.35% |
More ▼
Data from 30 Sep 2020 - 30 Sep 2020Source: FactSet Research Systems Inc.
